Citigroup
MAIA icon

Citigroup’s MAIA Biotechnology MAIA Stock Holding History

Citigroup’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31 Sell
22
-1,716
-99% -$3.16K ﹤0.01% 5676
2025
Q4 		$2.66K Buy
1,738
+1,208
+228% +$1.58K ﹤0.01% 5406
2025
Q3 		$816 Buy
+530
New +$866 ﹤0.01% 5657

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's MAIA Position: Q1 2026 in Review

Citigroup reduced its MAIA Biotechnology (MAIA) stake by 99% in Q1 2026, selling an estimated $3.16K and leaving 22 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #5676.

Citigroup first reported a position in MAIA in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.66K in Q4 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Citigroup held 22 shares of MAIA Biotechnology worth $31 as of Q1 2026.
  • Citigroup sold 1,716 MAIA Biotechnology shares in Q1 2026, an estimated $3.16K.
  • MAIA Biotechnology made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5676 holding.
  • Citigroup first reported a position in MAIA Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • Citigroup's MAIA Biotechnology position peaked at $2.66K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.